Prospective clinical validation of independent DVH prediction for plan QA in automatic treatment planning for prostate cancer patients

A high accuracy DVH prediction tool was developed and used for independent QA of automatically generated plans. In 28% of plans, minor dosimetric deviations were observed that could be improved by plan adjustments. Larger gains are expected for manually generated plans.